Sonoma Biotherapeutics Announces Positive Interim Safety and Efficacy Data from Phase 1 REGULATE-RA Study of SBT-77-7101 in Refractory Rheumatoid Arthritis Favorable early safety profile with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results